Humalog and Naltrexone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Naltrexone (naltrexone). Common drug interactions include sjogren's syndrome among females and dysuria among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Naltrexone. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,835 Naltrexone users. Check the latest studies of Naltrexone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

31 people who take Humalog and Naltrexone together, and have interactions are studied.

Humalog and Naltrexone drug interactions.

What are the common drug interactions of Humalog and Naltrexone, by gender? *:

female:

  1. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  2. Back pain
  3. Bipolar disorder (mood disorder)
  4. Disability
  5. Dry mouth
  6. Epigastric discomfort
  7. Gastric ulcer (stomach ulcer)
  8. Gastritis (inflammation of stomach)
  9. Gastrointestinal motility disorder (abnormal intestinal contractions)
  10. Abdominal discomfort

male:

  1. Dysuria (painful or difficult urination)
  2. Pain in extremity
  3. Cardiac disorder
  4. Oedema peripheral (superficial swelling)
  5. Peripheral swelling
  6. Suicidal ideation

What are the common drug interactions of Humalog and Naltrexone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal discomfort
  2. Back pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Influenza
  5. Insomnia (sleeplessness)
  6. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  7. Sputum discoloured
  8. Urinary tract infection
  9. Vulvovaginal mycotic infection (vulvovaginal fungal infection)

60+:

  1. Pain in extremity
  2. Alopecia (absence of hair from areas of the body)
  3. Muscle spasms (muscle contraction)
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema peripheral (superficial swelling)
  7. Parkinson's disease
  8. Renal artery stenosis (narrowing of renal artery)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Vomiting

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 35.48%
  2. Immunodeficiency Common Variable: 6 people, 19.35%
  3. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 12.90%
  4. Type 2 Diabetes: 3 people, 9.68%
  5. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 2 people, 6.45%
  6. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 6.45%
  7. Haemochromatosis (body to absorb more iron than usual from food): 2 people, 6.45%
  8. Heart Disease: 2 people, 6.45%
  9. High Blood Cholesterol: 2 people, 6.45%
  10. High Blood Pressure: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Naltrexone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humalog and Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naltrexone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant and naltrexone (the active ingredients of Humalog and Naltrexone, respectively), and Humalog and Naltrexone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: